PROBI AB |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 205 SEK | +0.49% |
|
-1.91% | +0.99% |
| May. 07 | Probi AB Approves Election of Stephanie Blum Sperisen as Board Member | CI |
| May. 07 | Probi AB Approves the Dividend for the Financial Year 2023 | CI |
Presentation Operator MessageOperator (Operator)Hello, and welcome to Probi AB Q4 Report 2019....
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe
Probi AB is a Sweden-based company engaged in the probiotics research and development. The Companyâs activities are divided into two business areas: Functional Foods, which focuses on the probiotics application in food in partnership with food companies; and Consumer Healthcares, which develops, commercializes and sells Probi probiotics in collaboration with a range of entities, such as pharmaceutical companies and firms related to the production of probiotics and self-care goods. Its brands portfolio comprises two trademarks: Probi Digestis and Probi Defendum. The Company's partners include Danone, Skanemejerier, NextFoods, Sanum Polska, Heinz, Kraft Foods, and Institut Rosell, among others. The Company is a parent of Probi Food AB and Probi Feed AB.
Sector
Pharmaceuticals
Calendar
2024-07-16
- Q2 2024 Earnings Release
Trading Rating
Investor Rating
ESG Refinitiv
C+
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +0.99% | 216M | |
| +30.38% | 684B | |
| +26.51% | 568B | |
| -4.36% | 361B | |
| +19.30% | 329B | |
| +3.73% | 284B | |
| +16.70% | 240B | |
| +8.78% | 208B | |
| -7.93% | 200B | |
| +7.68% | 166B |
- Stock Market
- Equities
- PROB Stock
- News Probi AB
- Transcript : Probi AB, Q4 2019 Earnings Call, Feb 11, 2020
